The most common reason for incarceration is related to minor drug offenses, mostly opioids. Increasingly, correctional facilities are providing access to medications for opioid use disorder through medication-assisted treatment programs, but many fall short of establishing a full opioid treatment program due to the many regulatory challenges. This presentation will discuss the DEA's regulatory framework for OTP programs in corrections and the compliance indicators for passing a DEA audit.

Educational Objectives

• Describe the DEA regulatory framework that guides the use of MOUD in OTP programs in corrections
• Discuss the diversion control plan necessary for a successful DEA OTP audit in corrections
• Summarize a continuous education initiative for meeting the DEA's OTP audit requirements in corrections

Level:Intermediate